2010 Q2WEEK CONTROLLED-RELEASE-INTERFERON-ALPHA2B + RIBAVRIN REDUCES FLU-LIKE SYMPTOMS >50% AND PROVIDES EQUIVALENT EFFICACY IN COMPARISON TO WEEKLY PEGYLATED-INTERFERON-ALPHA2B + RIBAVIRIN IN TREATMENT-NAIVE-GENOTYPE-1-CHRONIC-HEPATITIS-C: RESULTS FROM EMPOWER, A RANDOMIZED-OPEN-LABEL-12-WEEK-COMPARISON IN 133 PATIENTS
Keyword(s):
2009 ◽
Vol 23
(3)
◽
pp. 180-184
◽
Keyword(s):
2010 ◽
Vol 18
(4)
◽
pp. e99-e103
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 36
(4)
◽
pp. 370-378
◽
Keyword(s):
Keyword(s):